Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 42087-81-0 | MDL No. : | MFCD04038813 |
Formula : | C8H6ClNO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VTWUVGLVDQXCJO-UHFFFAOYSA-N |
M.W : | 215.59 | Pubchem ID : | 12187125 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 51.55 |
TPSA : | 72.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.99 cm/s |
Log Po/w (iLOGP) : | 1.51 |
Log Po/w (XLOGP3) : | 2.29 |
Log Po/w (WLOGP) : | 2.03 |
Log Po/w (MLOGP) : | 1.43 |
Log Po/w (SILICOS-IT) : | 0.22 |
Consensus Log Po/w : | 1.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.74 |
Solubility : | 0.394 mg/ml ; 0.00183 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.44 |
Solubility : | 0.0779 mg/ml ; 0.000361 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.48 |
Solubility : | 0.717 mg/ml ; 0.00333 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.05 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
79% | With iron; acetic acid In ethanol at 20℃; for 2 h; Heating / reflux | Methyl 2-amino-3-chlorobenzoate. Iron powder (1.94 g, 34.8 mmol) was added to the solution of methyl 3-chloro-2-nitrobenzoate (2.5 g, 111.6 mmol) in EtOH/HOAc (100 mL/100 mL) at room temperature, and then the suspension was refluxed under N2 for 2 hrs. After cooling down to room temperature, partial of the solvents was removed on rotary vacuum, the resulting residue was partitioned between H2O/EtOAc (200 mL/300 mL). The separated organic phase was washed with aqueous NaOH (1N, 50 mL), brine (50 mL), dried over MgSO4, and concentrated on rotary vacuum to afford the expected product as a tan oil (1.7 g, 79percent yield) which became wax type solid standing on bench. The crude product was pure enough to be used in next step without further purification; 1H NMR (400 MHz, CDCl3) δ ppm 3.86 (s, 3H), 6.25 (s, 2H), 6.57 (t, J=7.93 Hz, 1H), 7.39 (dd, J=7.81, 1.51 Hz, 1H), 7.79 (dd, J=8.06, 1.51 Hz, 1H); Mass spec. 185.95 (MH+), Calc. for C8H8ClNO2 185.02. |
79% | Stage #1: With iron; acetic acid In ethanol at 20℃; for 2 h; Heating / reflux Stage #2: With sodium hydroxide In water; ethyl acetate |
Methyl 2-amino-3-chlorobenzoate; Iron powder (1.94 g, 34.8 mmol) was added to the solution of methyl 3-chloro-2-nitrobenzoate (2.5 g, 11.6 mmol) in EtOH/HOAc (100 mL/100 mL) at room temperature, and then the suspension was refluxed under N2 for 2 hrs. After cooling down to room temperature, partial of the solvents was removed on rotary vacuum, the resulting residue was partitioned between H2O/EtOAc (200 mL/300 mL). The separated organic phase was washed with aqueous NaOH (1N, 50 mL), brine (50 mL), dried over MgSO4, and concentrated on rotary vacuum to afford the expected product as a tan oil (1.7 g, 79percent yield) which became wax type solid standing on bench. The crude product was pure enough to be used in next step without further purification; 1H NMR (400 MHz, CDCl3) δ ppm 3.86 (s, 3 H), 6.25 (s, 2 H), 6.57 (t, J=7.93 Hz, 1 H), 7.39 (dd, J=7.81, 1.51 Hz, 1 H), 7.79 (dd, J=8.06, 1.51 Hz, 1 H); Mass spec. 185.95 (MH+), Calc. for C8H8ClNO2 185.02. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With diisobutylaluminium hydride In dichloromethane at -78℃; for 0.25 h; | Example 116; This example concerns the synthesis of Aldehyde 12: To a stirred solution of 81 (2.91 g, 13.5 mmol) and CH2Cl2 (134 mL) at -78°C was added DIBAL-H (16.0 mL, 16.0 mmol, 1.0 M in CH2Cl2) over 15 min. After an additional 10 min, the reaction was quenched with MeOH (1.0 mL) and warmed to rt. Next, a solution of aq. sodium potassium tartrate (190 mL, 10percent w/v) was added and vigorously stirred. After 4 h, the reaction mixture was diluted with CH2Cl2 (50 mL) and washed with H2O (3 x 100 mL) and sat. aq. NaCl (100 mL). The dried extract (MgSO4) was concentrated in vacuo and purified by recrystallization with EtOAc / Hexanes (1 :3) to give known aldehyde 12 (2.32 g, 12.7 mmol, 94percent) as a white crystalline solid. 1H NMR (400 MHz, CDCl3) δ 9.90 (s, IH), 7.92 (dd, J= 1.4, 7.7 Hz, IH), 7.80 (dd, J= 1.4, 8.1 Hz, IH), 7.67 (dd, J= 7.7, 8.1 Hz, IH); 13C NMR (100 MHz, CDCl3) δ 186.0, 148.1 136.0, 131.7, 130.1, 128.5, 126.6. |
[ 623588-40-9 ]
Methyl 5-chloro-4-fluoro-2-nitrobenzoate
Similarity: 0.83
[ 1204518-43-3 ]
Isopropyl 5-chloro-4-methyl-2-nitrobenzoate
Similarity: 0.83
[ 2011-09-8 ]
4,5-Dichloro-2-nitrobenzoic acid
Similarity: 0.83
[ 172217-16-2 ]
Ethyl 2-chloro-6-nitrobenzoate
Similarity: 0.83
[ 101495-62-9 ]
Methyl 2,4-dichloro-5-nitrobenzoate
Similarity: 0.83
[ 174456-26-9 ]
2-Amino-4-chloro-6-nitrobenzoic acid
Similarity: 0.83
[ 623588-40-9 ]
Methyl 5-chloro-4-fluoro-2-nitrobenzoate
Similarity: 0.83
[ 1204518-43-3 ]
Isopropyl 5-chloro-4-methyl-2-nitrobenzoate
Similarity: 0.83
[ 2011-09-8 ]
4,5-Dichloro-2-nitrobenzoic acid
Similarity: 0.83
[ 172217-16-2 ]
Ethyl 2-chloro-6-nitrobenzoate
Similarity: 0.83
[ 55775-99-0 ]
Methyl 2,6-dichloro-3-nitrobenzoate
Similarity: 0.83
[ 5471-82-9 ]
Methyl 3-methyl-2-nitrobenzoate
Similarity: 0.83
[ 861593-27-3 ]
3-(Methoxycarbonyl)-2-nitrobenzoic acid
Similarity: 0.83
[ 76143-33-4 ]
5-(Methoxycarbonyl)-2-nitrobenzoic acid
Similarity: 0.83
[ 174456-26-9 ]
2-Amino-4-chloro-6-nitrobenzoic acid
Similarity: 0.83
[ 623588-40-9 ]
Methyl 5-chloro-4-fluoro-2-nitrobenzoate
Similarity: 0.83
[ 1204518-43-3 ]
Isopropyl 5-chloro-4-methyl-2-nitrobenzoate
Similarity: 0.83
[ 2011-09-8 ]
4,5-Dichloro-2-nitrobenzoic acid
Similarity: 0.83
[ 172217-16-2 ]
Ethyl 2-chloro-6-nitrobenzoate
Similarity: 0.83